ClinicalTrials.gg
CompletedNCT03463122Updated Mar 13, 2018

Head Mount Display-based Virtual Reality Rehabilitation of Hemispatial Neglect

An interventional study of field of regard-focused visual exploration therapy and conventional therapy in Stroke and Neglect, Hemispatial, sponsored by National Rehabilitation Center, Seoul, Korea. Completed at 1 site in Korea, Republic of. Open to participants aged 19 Years and older. Per ClinicalTrials.gov, last updated 2018-03-13.

Sponsored by National Rehabilitation Center, Seoul, Korea · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 3 years 7 months after the study started (first participant enrolled Aug 2014, registered Mar 2018).
Phase
Not applicable
Study type
Interventional
Enrollment
56
Allocation
Randomized
Ages
19 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 20 studies in Stroke by National Rehabilitation Center, Seoul, Korea — none open to participants now, none under way, none of them phase 3. Stroke · National Rehabilitation Center, Seoul, Korea.

Enrollment
5th of 19
56 · median 30
Started
2014
with 4 others
No phase
17 of 20
none open now
Registered
11th of 20
by date

Among the 20 studies in Stroke by National Rehabilitation Center, Seoul, Korea, this one is the 5th largest by enrollment of the 19 interventional ones that give a count, is one of 5 that started in 2014, is one of 17 with no phase, and was the 11th registered.

Stroke

8,255 studies on the registry are indexed under Stroke; 2,056 are open to participants now.

Browse Stroke studies →

Open to participants now

None of the 20 studies in Stroke by National Rehabilitation Center, Seoul, Korea is open now. The open studies under Stroke, anywhere →

Where they have run

Who these studies take

Of the 1,415 Stroke studies recruiting now, 697 (49%) set no upper age limit and 280 (20%) stop at 75 or younger; 77 take children under 18; 196 take healthy volunteers.

This study: 19 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Download CSVNarrow it in search →With an account: the 20 studies in Stroke by National Rehabilitation Center, Seoul, Korea as a file.
02

Study summary

Head-mounted display based virtual reality rehabilitation for hemispatial neglect.

Read the detailed description

The investigators examine about the efficacy of field-of-regard-focused visual exploration therapy implemented using a head-mounted display virtual reality system for hemispatial neglect rehabilitation following stroke.

03

Conditions studied

  • Stroke
  • Neglect, Hemispatial

Keywords

  • stroke
  • neglect
  • virtual reality
  • head mount display
  • rehabilitation
04

Who can participate

Ages eligible
19 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • presence of left hemispatial neglect as demonstrated by a score above the cut-off on the line bisection test or star cancellation test of the Behavioral Inattention Test, or mild-to-moderate neglect-related functional impairment defined by a score of 1-20 points on the Catherine Bergego Scale
  • age 19 to 65 years
  • first-time right hemispheric ischemic or haemorrhagic stroke as evidenced by brain imaging and medical records
  • a score >25 on the

Exclusion criteria

Exclusion Criteria:

  • presence of oculomotor palsies or visual defects as assessed via standard neurological examination
  • orthopaedic disorders affecting neck movement
  • inability to maintain a seated position.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Outcomes assessor)
Enrollment
56 participants (actual)

Study arms

  • Other
    Training first

    This group completed 20 sessions of a field of regard-focused visual exploration therapy program using an head mount display (five daily sessions per week over a period of four weeks) in addition to conventional therapy followed by four weeks of conventional therapy

    Device: field of regard-focused visual exploration therapy · Other: conventional therapy

  • Other
    Waiting first

    This group completed four weeks of conventional therapy followed by 20 sessions of a field of regard-focused visual exploration therapy program using an head mount display (five daily sessions per week over a period of four weeks) in addition to conventional therapy.

    Device: field of regard-focused visual exploration therapy · Other: conventional therapy

Interventions

  • Devicefield of regard-focused visual exploration therapy

    field of regard-focused visual exploration therapy in addition to conventional therapy

    Also known as: head mount display

  • Otherconventional therapy

    conventional therapy for stroke rehabilitation

06

What researchers measure

Primary outcomes

  1. Change in Field of regard-response time

    time interval between target onset and response with field of regard setting

    Time frame: Baseline, 4 weeks from baseline, 8 weeks from baseline

  2. Change in Field of regard-success rate

    percentage of correct responses (clicking the left or right mouse button in response to a blue or red target, respectively) with field of regard setting

    Time frame: Baseline, 4 weeks from baseline, 8 weeks from baseline

  3. Change in Field of regard-head movement

    sum of all quantified head-rotations with field of regard setting

    Time frame: Baseline, 4 weeks from baseline, 8 weeks from baseline

Secondary outcomes

  1. Field of view-response time

    time interval between target onset and response with field of view setting

    Time frame: Baseline, 4 weeks from baseline, 8 weeks from baseline

  2. Field of view-success rate

    percentage of correct responses (clicking the left or right mouse button in response to a blue or red target, respectively) with field of view setting

    Time frame: Baseline, 4 weeks from baseline, 8 weeks from baseline

  3. Line bisection test

    Participants were asked to bisect the given lines by marking the centre of each line using their preferred or unaffected hand

    Time frame: Baseline, 4 weeks from baseline, 8 weeks from baseline

  4. Star cancellation test

    The experimenter crossed out the two small, central stars of the sheet as an example, following which participants were asked to mark the remaining small stars.

    Time frame: Baseline, 4 weeks from baseline, 8 weeks from baseline

  5. Catherine Bergego Scale

    a standardised checklist designed to detect the degree of neglect during everyday life via direct observation of functioning during ten tasks

    Time frame: Baseline, 4 weeks from baseline, 8 weeks from baseline

07

Study locations

1 site
  • National Rehabilitation Center
    Seoul, 01022, Korea, Republic of
08

References and documents

Publications

  • Kim TL, Kim K, Choi C, Lee JY, Shin JH. FOPR test: a virtual reality-based technique to assess field of perception and field of regard in hemispatial neglect. J Neuroeng Rehabil. 2021 Feb 18;18(1):39. doi: 10.1186/s12984-021-00835-1. PubMed 33602254 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Aug 2014 to primary completion in Oct 2016, 26 months.

Of 3,108 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's 26 months is above that.

Counting every sponsor, half of 3,252 studies reached it within 23 months; a quarter within 10 and three quarters within 46.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 5, 2018
First posted
Mar 13, 2018
StartActual
Aug 1, 2014
Primary completionActual
Oct 30, 2016
CompletionActual
Dec 31, 2016
Last update
Mar 13, 2018
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 13, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03463122
Lead sponsor
National Rehabilitation Center, Seoul, Korea
Collaborators
Hanyang University
Responsible party
Joon-Ho Shin (Team manager of Department of Neurorehabilitation, National Rehabilitation Center, Seoul, Korea) — Principal investigator
First posted
Mar 13, 2018
Start date
Aug 1, 2014
Primary completion
Oct 30, 2016
Completion
Dec 31, 2016
Last update
Mar 13, 2018

Study contacts

Joon-Ho Shin
principal investigator · National Rehabilitation Center of Korea

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion